Clinical application of monoclonal antibody-drug conjugates for immunotargeting chemotherapy of colorectal carcinoma.
about
Active drug targeting with immunoconjugates to choroidal neovascularization.Targeting immunotherapy using the avidin-biotin system for a human colon adenocarcinoma in vitro.Biorecognition of antibodies in vivo: potential in drug targeting.In vitro reactivity and in vivo biodistribution of the monoclonal antibody A7 using human gastric carcinoma cell lines.Follow-up study of patients treated with monoclonal antibody-drug conjugate: report of 77 cases with colorectal cancer.In vitro and preclinical studies of targeted alpha therapy (TAT) for colorectal cancer.Development of human anti-murine antibody (HAMA) response in patients.Enhanced tumor localization of radiolabeled Fab fragments of monoclonal antibody A7 in nude mice bearing human pancreatic carcinoma xenografts.Enhanced tumor localization of monoclonal antibody by treatment with kininase II inhibitor and angiotensin II.Biodistribution of neocarzinostatin conjugated to chimeric Fab fragments of the monoclonal antibody A7 in nude mice bearing human pancreatic cancer xenografts.Efficacy and specificity of a monoclonal antibody-drug conjugate in chemotherapy by intratumoral injection.Rhenium-186-mercaptoacetyltriglycine-labeled monoclonal antibody for radioimmunotherapy: in vitro assessment, in vivo kinetics and dosimetry in tumor-bearing nude mice.Tumor localization and in vivo antitumor activity of the immunoconjugate composed of anti-human colon cancer monoclonal antibody and mitomycin C-dextran conjugate.Production, binding and cytotoxicity of human/mouse chimeric monoclonal antibody-neocarzinostatin conjugate.Comparative pharmacokinetic properties of murine monoclonal antibody A7 modified with neocarzinostatin, dextran and polyethylene glycol.Decreased renal accumulation of biotinylated chimeric monoclonal antibody-neocarzinostatin conjugate after administration of avidin.
P2860
Q30659904-F49328F6-AFE1-4C3E-9104-15986EE442DDQ41141793-EB8FC849-FA8C-440A-A73F-DF8E64D147F1Q41491098-A75B36CD-9DB3-474B-ABB4-7F7B4B83DD49Q42255962-A7F1901A-C1F9-45BA-806E-2DEC9036B45EQ43435802-A856960F-6A97-492A-80C7-0AE6FF164018Q44468366-E49FBC2C-CB57-4AC5-8E06-3529D6C7EAEEQ44592219-752CC4CA-9F5A-443C-869F-7D0E7464B288Q54941920-1BEFDDC1-C325-4C71-8C53-A5986AEE8CBFQ55007010-7BD51AFD-2CF5-42F2-A10A-6622F9D9BFBAQ55034672-7AC009AF-B12C-46B2-A770-7B61E435B3BBQ55040545-8EEC18D9-4D81-42D7-A945-9324256F21D1Q55048014-50C6D6F9-44F4-45E8-99F9-B43167DEEC04Q55121197-25B77C1B-DF73-4AC9-99FC-5AF6CA162888Q55171953-6F7F417F-05A9-4418-8153-1EEF51B2679CQ55266469-AEA00B41-13F7-4A8F-80B9-11E9DC4D017EQ55322128-E5E5CD52-6B85-4AFA-9AC3-670A0FF13942
P2860
Clinical application of monoclonal antibody-drug conjugates for immunotargeting chemotherapy of colorectal carcinoma.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Clinical application of monocl ...... erapy of colorectal carcinoma.
@en
Clinical application of monocl ...... erapy of colorectal carcinoma.
@nl
type
label
Clinical application of monocl ...... erapy of colorectal carcinoma.
@en
Clinical application of monocl ...... erapy of colorectal carcinoma.
@nl
prefLabel
Clinical application of monocl ...... erapy of colorectal carcinoma.
@en
Clinical application of monocl ...... erapy of colorectal carcinoma.
@nl
P2093
P1433
P1476
Clinical application of monocl ...... erapy of colorectal carcinoma.
@en
P2093
Hashimoto Y
Kitamura K
Kotanagi H
Suzuyama H
Takahashi M
Takahashi T
Yamaguchi T
P304
P356
10.1002/1097-0142(19880301)61:5<881::AID-CNCR2820610505>3.0.CO;2-Y
P407
P577
1988-03-01T00:00:00Z